CODX · Co-Diagnostics, Inc.
$1.40
-0.09 (-6.04%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because certain elements of management's plans to mitigate the conditions that raised substantial doubt about the Company's ability to continue as a going concern are outside of the Company's control, including the ability to raise capital through equity or other financings, those elements cannot be considered probable according to ASC 205-40, and therefore cannot be considered in the evaluation of mitigating factors. As a result, management has concluded that substantial doubt exists about the Company's ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$8.75M
Shares
6.25M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding CODX
3 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Snow Capital Small Cap Value Fund | APCB | 28,914 | $310,826 | 1.36% | Long | 2021-08-31 | |
| Hancock Horizon Microcap Fund | ARP | 8,181 | $67,493 | 0.48% | Long | 2021-06-30 | |
| Fidelity Nasdaq Composite Index Fund | — | 39 | $333 | 0.00% | Long | 2026-05-31 |
Showing 1–3 of 3 positions
Key facts
CIK
1692415
CUSIP
189763204
13F (30d)
26 filings
24 filers
Visit website
Investor relations